Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Clinical trial NCT00473083 · COMPLETED
Trial details
- NCT number
- NCT00473083
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.